Tang Ying-Mei, Chen Min-Hu, Chen Gui-Hua, Cai Chang-Jie, He Xiao-Shun, Lu Min-Giang, Bao Wei-Min
Department of Gastroenterology, the First Affiliated Hospital of Sun-Yat Sen University, Guangzhou 510080, Guangdong Province, China.
World J Gastroenterol. 2005 Aug 7;11(29):4574-8. doi: 10.3748/wjg.v11.i29.4574.
To study the association between host immunity and hepatitis B virus (HBV) recurrence after liver transplantation.
Peripheral blood mononuclear cells (PBMC) were isolated from 40 patients with hepatitis B and underwent orthotopic liver transplantation (OLT) before and 2, 4, 8 wk after surgery. After being cultured in vitro for 72 h, the levels of INF-gamma and TNF-alpha in culture supernatants were detected with ELISA. At the same time, the quantities of HBV DNA in serum and PBMCs were measured by real time PCR.
The levels of INF-gamma and TNF-alpha in PBMC culture supernatants decreased before and 2, 4 wk after surgery in turns (INF-gamma 155.52+/-72.32 ng/L vs 14.76+/-9.88 ng/L vs 13.22+/-10.35 ng/L, F = 6.946, P = 0.027 < 0.05; TNF-alpha 80.839+/-46.75 ng/L vs 18.59+/-17.29 ng/L vs 9.758+/-7.96 ng/L, F = 22.61, P = 0.0001 < 0.05). The levels of INF-gamma and TNF-alpha were higher in groups with phytohemagglutinin (PHA) than in those without PHA before surgery. However, the difference disappeared following OLT. Furthermore, INF-gamma and TNF-alpha could not be detected in most patients at wk 4 and none at wk 8 after OLT. The HBV detection rate and virus load in PBMC before and 2, 4 wk after surgery were fluctuated (HBV detected rate: 51.4%, 13.3%, 50% respectively; HBV DNA: 3.55+/-0.674 log10 copies/mL vs 3.00+/-0.329 log10 copies/mL vs 4.608+/-1.344 log10 copies/mL, F = 7.582, P = 0.002 < 0.05). HBV DNA in serum was 4.48+/-1.463 log10 copies/mL before surgery and <10(3) copies/mL after OLT except for one with 5.72 x 10(6) copies/mL 4 wk after OLT who was diagnosed as HBV recurrence. The levels of INF-gamma and TNF-alpha were lower in patients with a high HBV load than in those with a low HBV load (HBV DNA detected/undetected in PBMCs: IFN-gamma 138.08+/-72.44 ng/L vs 164.24+/-72.07 ng/L, t = 1.065, P = 0.297 > 0.05, TNF-alpha 80.75+/-47.30 ng/L vs 74.10+/-49.70 ng/L, t = 0.407, P = 0.686 > 0.05; HBV DNA positive/negative: IFN-gamma 136.77+/-70.04 ng/L vs 175.27+/-71.50 ng/L, t = 1.702, P = 0.097 > 0.05; TNF-alpha 75.37+/-43.02 ng/L vs 81.53+/-52.46 ng/L, t = 0.402, P = 0.690 > 0.05).
The yielding of INF-gamma and TNF-alpha from PBMCs is inhibited significantly by immunosuppressive agents following OLT with HBV load increased, indicating that the impaired immunity of host is associated with HBV recurrence after OLT.
研究肝移植术后宿主免疫与乙型肝炎病毒(HBV)复发之间的关联。
从40例乙型肝炎患者中分离出外周血单个核细胞(PBMC),于肝移植手术前及术后2、4、8周进行检测。体外培养72小时后,采用酶联免疫吸附测定法(ELISA)检测培养上清液中INF-γ和TNF-α的水平。同时,采用实时聚合酶链反应(PCR)检测血清及PBMC中HBV DNA的含量。
术后2周及4周时,PBMC培养上清液中INF-γ和TNF-α水平依次降低(INF-γ:155.52±72.32 ng/L vs 14.76±9.88 ng/L vs 13.22±10.35 ng/L,F = 6.946,P = 0.027 < 0.05;TNF-α:80.839±46.75 ng/L vs 18.59±17.29 ng/L vs 9.758±7.96 ng/L,F = 22.61,P = 0.0001 < 0.05)。术前,植物血凝素(PHA)刺激组的INF-γ和TNF-α水平高于无PHA刺激组。然而,肝移植术后这种差异消失。此外,肝移植术后4周时,大多数患者无法检测到INF-γ和TNF-α,8周时均未检测到。术后2周及4周时,PBMC中HBV检测率及病毒载量出现波动(HBV检测率分别为51.4%、13.3%、50%;HBV DNA:3.55±0.674 log10拷贝/mL vs 3.00±0.329 log10拷贝/mL vs 4.608±1.344 log10拷贝/mL,F = 7.582,P = 0.002 < 0.05)。术前血清HBV DNA为4.48±1.463 log10拷贝/mL,肝移植术后除1例术后4周时HBV DNA为5.72×10⁶拷贝/mL被诊断为HBV复发外,其余患者均<10³拷贝/mL。HBV载量高的患者,其INF-γ和TNF-α水平低于HBV载量低的患者(PBMC中HBV DNA检测到/未检测到:IFN-γ 138.08±72.44 ng/L vs 164.24±72.07 ng/L,t = 1.065,P = 0.297 > 0.05;TNF-α 80.75±47.30 ng/L vs 74.10±49.70 ng/L,t = 0.407,P = 0.686 > 0.05;HBV DNA阳性/阴性:IFN-γ 136.77±70.04 ng/L vs 175.27±71.50 ng/L,t = 1.702,P = 0.097 > 0.05;TNF-α 75.37±43.02 ng/L vs 81.53±52.46 ng/L,t = 0.402,P = 0.690 > 0.05)。
肝移植术后免疫抑制剂显著抑制PBMC产生INF-γ和TNF-α,同时HBV载量增加,提示宿主免疫功能受损与肝移植术后HBV复发有关。